Citadel Advisors’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344K Buy
+15,100
New +$357K ﹤0.01% 10157
2025
Q4
Sell
-23,100
Closed -$701K 12981
2025
Q3
$701K Buy
23,100
+2,900
+14% +$87.9K ﹤0.01% 8327
2025
Q2
$633K Buy
20,200
+3,600
+22% +$119K ﹤0.01% 8071
2025
Q1
$634K Sell
16,600
-31,000
-65% -$1.32M ﹤0.01% 7950
2024
Q4
$2.09M Buy
47,600
+23,100
+94% +$1.01M ﹤0.01% 5536
2024
Q3
$1.05M Buy
24,500
+8,200
+50% +$365K ﹤0.01% 6766
2024
Q2
$737K Sell
16,300
-16,200
-50% -$841K ﹤0.01% 7251
2024
Q1
$2.03M Buy
32,500
+13,776
+74% +$824K ﹤0.01% 5488
2023
Q4
$1.05M Buy
18,724
+8,366
+81% +$417K ﹤0.01% 6582
2023
Q3
$546K Buy
10,358
+2,600
+34% +$152K ﹤0.01% 7859
2023
Q2
$497K Buy
7,758
+3,000
+63% +$171K ﹤0.01% 7953
2023
Q1
$255K Sell
4,758
-2,755
-37% -$160K ﹤0.01% 9718
2022
Q4
$402K Sell
7,513
-2,298
-23% -$119K ﹤0.01% 8704
2022
Q3
$452K Buy
9,811
+3,573
+57% +$194K ﹤0.01% 8681
2022
Q2
$343K Sell
6,238
-6,776
-52% -$437K ﹤0.01% 9505
2022
Q1
$891K Buy
13,014
+1,394
+12% +$99.3K ﹤0.01% 7976
2021
Q4
$919K Sell
11,620
-7,902
-40% -$661K ﹤0.01% 8159
2021
Q3
$1.54M Sell
19,522
-5,054
-21% -$406K ﹤0.01% 7017
2021
Q2
$1.94M Sell
24,576
-1,918
-7% -$147K ﹤0.01% 6702
2021
Q1
$2M Buy
26,494
+7,844
+42% +$575K ﹤0.01% 6390
2020
Q4
$1.23M Sell
18,650
-2,092
-10% -$122K ﹤0.01% 6356
2020
Q3
$1.12M Sell
20,742
-6,739
-25% -$370K ﹤0.01% 5837
2020
Q2
$1.32M Buy
27,481
+2,149
+8% +$94.9K ﹤0.01% 5321
2020
Q1
$863K Buy
25,332
+13,596
+116% +$747K ﹤0.01% 5592
2019
Q4
$735K Sell
11,736
-8,018
-41% -$453K ﹤0.01% 6154
2019
Q3
$988K Sell
19,754
-3,312
-14% -$156K ﹤0.01% 5615
2019
Q2
$1.11M Sell
23,066
-6,042
-21% -$291K ﹤0.01% 5524
2019
Q1
$1.49M Buy
29,108
+11,678
+67% +$512K ﹤0.01% 4927
2018
Q4
$627K Buy
17,430
+8,076
+86% +$377K ﹤0.01% 6053
2018
Q3
$581K Buy
+9,354
New +$533K ﹤0.01% 6459
2018
Q1
Sell
-6,798
Closed -$464K 8385
2017
Q4
$464K Sell
6,798
-3,544
-34% -$239K ﹤0.01% 5767
2017
Q3
$741K Buy
10,342
+4,358
+73% +$303K ﹤0.01% 4754
2017
Q2
$406K Buy
5,984
+1,859
+45% +$127K ﹤0.01% 5423
2017
Q1
$279K Sell
4,125
-7,902
-66% -$527K ﹤0.01% 5979
2016
Q4
$744K Buy
12,027
+8,309
+223% +$491K ﹤0.01% 4289
2016
Q3
$201K Sell
3,718
-2,499
-40% -$126K ﹤0.01% 6301
2016
Q2
$283K Sell
6,217
-4,880
-44% -$238K ﹤0.01% 5299
2016
Q1
$546K Buy
11,097
+8,599
+344% +$366K ﹤0.01% 4288
2015
Q4
$100K Sell
2,498
-2,905
-54% -$133K ﹤0.01% 6688
2015
Q3
$278K Sell
5,403
-2,324
-30% -$154K ﹤0.01% 5683
2015
Q2
$614K Buy
7,727
+2,266
+41% +$192K ﹤0.01% 4659
2015
Q1
$449K Sell
5,461
-4,242
-44% -$355K ﹤0.01% 5061
2014
Q4
$861K Sell
9,703
-58
-0.6% -$5.25K ﹤0.01% 3947
2014
Q3
$957K Sell
9,761
-21,148
-68% -$2.38M ﹤0.01% 3749
2014
Q2
$3.97M Buy
30,909
+25,448
+466% +$3.18M ﹤0.01% 2042
2014
Q1
$671K Buy
5,461
+3,718
+213% +$427K ﹤0.01% 3961
2013
Q4
$191K Buy
1,743
+290
+20% +$29K ﹤0.01% 5070
2013
Q3
$141K Sell
1,453
-5,345
-79% -$493K ﹤0.01% 5067
2013
Q2
$610K Buy
+6,798
New +$560K ﹤0.01% 3647

Other funds holding ENOV

Citadel Advisors's ENOV Position: Q1 2026 in Review

Citadel Advisors increased its Enovis (ENOV) stake by 232% in Q1 2026, buying an estimated $12.9M and bringing the position to 781,761 shares worth $17.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Citadel Advisors first reported a position in ENOV in Q2 2013 and has held it in 49 quarters since. The position peaked at $78.4M in Q4 2017. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • Citadel Advisors held 781,761 shares of Enovis worth $17.8M as of Q1 2026.
  • Citadel Advisors bought 546,383 Enovis shares in Q1 2026, an estimated $12.9M.
  • Enovis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2471 holding.
  • Citadel Advisors first reported a position in Enovis in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Enovis position peaked at $78.4M in Q4 2017.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.